Stock Market

If you’re seeking exposure to the cybersecurity and artificial intelligence market, you may be tempted to load up on Palantir Technologies (NYSE:PLTR) stock. After all, a famous tech-market investor recently bought millions of shares of Palantir. Don’t hit the “buy” button, though, until you’ve considered a potential issue with one of Palantir’s government contracts. Also, remember
0 Comments
Founded in 2009, C3.ai (NYSE:AI) aims to empower businesses with artificial intelligence. CEO Thomas Siebel, who offers over 40 customizable AI applications across various industries, sees the AI opportunity as transformative as the internet or smartphones. Recent fiscal 2024 Q2 results reveal notable growth in customer engagements and revenue, prompting investor consideration. This has considerable
0 Comments
In a fiercely competitive electric vehicle manufacturing industry, Rivian Automotive (NASDAQ:RIVN) faces hurdles in selling vehicles and achieving profitability. Consequently, RIVN stock may be exposed in 2024, potentially relinquishing recent gains.  Though Rivian has seen its stock price rally roughly 50% off of this year’s lows, it’s still trading well below its previous meme-cycle peak.
0 Comments
Palantir Technologies (NYSE:PLTR) has been among the most clear-cut winners of the surge in AI stocks. Indeed, the run PLTR stock has seen over the past year has put many top AI plays to shame. This is a company that’s still well off its meme-cycle highs. However, strong momentum is backing this company, and retail
0 Comments
There’s no denying that Advanced Micro Devices (NASDAQ:AMD) is a strong competitor among artificial intelligence chip makers. On the other hand, the company’s future growth and success may already be factored into the AMD share price. Therefore, we’re assigning a “B” grade to AMD stock with a cautiously optimistic outlook. If you’re seeking exposure to the
0 Comments
2023 proved to be a wild year, as many investors’ top-performing stocks quickly swirled down the drain amid higher interest rates and tightened economic conditions. But, against all odds, the market outlook improved rapidly in early fall before kicking off an early start to the Santa rally. While it’s too early to say for sure,
0 Comments
With such a high demand for items that can improve our longevity and health, biotechnology is at the forefront of today’s innovation. Biotech products allow us to better understand the human body and how we can improve functioning within the body. Unsurprisingly, these innovative technologies have developed wide consumer bases. They have also garnered consistent
0 Comments
As a member of the “Magnificent Seven,” Apple (NASDAQ:AAPL) earned the market’s favor throughout 2023. However, this doesn’t guarantee similar results for Apple’s investors in 2024. Overall, the outlook for AAPL stock is good and we’re assigning it a “B” grade, but there’s no urgency to buy it now if you don’t want to. It’s amazing to consider how
0 Comments